(Q44351438)

2 December 2017

title

Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene (English)

1 reference

2 December 2017

Eliza B Geer

1

1 reference

2 December 2017

Rita E Landman

2

1 reference

2 December 2017

Sharon L Wardlaw

3

1 reference

2 December 2017

Irene M Conwell

4

1 reference

2 December 2017

Pamela U Freda

5

1 reference

2 December 2017

publication date

1 January 2005

1 reference

2 December 2017

1 reference

2 December 2017

volume

8

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

115-122

1 reference

https://scigraph.springernature.com/pub.10.1007/s11102-005-5227-6

2 December 2017

exact match

0 references

cites work

Assessing the hypothalamo-pituitary-adrenocortical axis using physiological doses of adrenocorticotropic hormone

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-005-5227-6

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

21 January 2018

1 reference

12 December 2020

A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome

1 reference

12 December 2020

The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.

1 reference

12 December 2020

Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test.

1 reference

12 December 2020

Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion tests

1 reference

12 December 2020

Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease

1 reference

12 December 2020

The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency

1 reference

12 December 2020

Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.

1 reference

12 December 2020

Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats

1 reference

12 December 2020

Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency

1 reference

12 December 2020

Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *

1 reference

12 December 2020

A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic‐pituitary‐adrenal axis in normal man

1 reference

12 December 2020

Clinical review 62: Laboratory assessment of adrenal insufficiency

1 reference

12 December 2020

Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test

1 reference

12 December 2020

Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes.

1 reference

12 December 2020

Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.

1 reference

12 December 2020

The use of nalmefene for intrathecal opioid-associated nausea in postpartum patients.

1 reference

12 December 2020

Pituitary adrenal recovery following short-term suppression with corticosteroids

1 reference

12 December 2020

Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm

1 reference

12 December 2020

beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects

1 reference

12 December 2020

A comparison of the naloxone test with the insulin stress test in patients following transsphenoidal surgery.

1 reference

12 December 2020

Diagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test

1 reference

12 December 2020

Short-term hormonal effects of naloxone in man

1 reference

12 December 2020

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

12 December 2020

Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies.

1 reference

12 December 2020

Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency

1 reference

12 December 2020

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.

1 reference

12 December 2020

Comparison of the Low Dose Short Synacthen Test (1 g), the Conventional Dose Short Synacthen Test (250 g), and the Insulin Tolerance Test for Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients with Pituitary Disease

1 reference

12 December 2020

Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose

1 reference

12 December 2020

The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing Hormone

1 reference

12 December 2020

Value of the 30-Minute Adrenocorticotropin (ACTH) Test in Demonstrating Hypothalamic-Pituitary-Adrenocortical Insufficiency after Acute ACTH Deprivation

1 reference

12 December 2020

The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency

1 reference

12 December 2020

Binding of a new opiate antagonist, nalmefene, to rat brain membranes.

1 reference

12 December 2020

A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest.

1 reference

12 December 2020

Morphine inhibits cortisol and stimulates prolactin secretion in man

1 reference

12 December 2020

Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol

1 reference

12 December 2020

Effect of Insulin Induced Hypoglycemia on ACTH, Cortisol, and Growth Hormone Release in Man

1 reference

12 December 2020

Adrenal insufficiency

1 reference

12 December 2020

Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators

1 reference

12 December 2020

A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function.

1 reference

12 December 2020

Recovery of hypothalamo-pituitary-adrenal function in asthmatics whose oral steroids have been stopped or reduced

1 reference

12 December 2020

Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease

1 reference

12 December 2020

10.1007/S11102-005-5227-6

Identifiers

DOI

1 reference

2 December 2017

1 reference